These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3753032)

  • 1. The carcinogenic properties of topical PUVA. A lifelong study in mice.
    Hannuksela M; Stenbäck F; Lahti A
    Arch Dermatol Res; 1986; 278(5):347-51. PubMed ID: 3753032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of PUVA on langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen.
    Kuusilehto A; Happonen RP; Peltola J; Lehtinen R; Jansén CT
    Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):129-33. PubMed ID: 10885443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
    Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
    Granstein RD; Morison WL; Kripke ML
    Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
    Koulu LM; Jansén CT
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action spectra of topical psoralens: a re-evaluation.
    Cripps DJ; Lowe NJ; Lerner AB
    Br J Dermatol; 1982 Jul; 107(1):77-82. PubMed ID: 7104210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
    Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
    Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
    Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater.
    Wainwright NJ; MacLeod TM; Ferguson J
    Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the immunologic reactivity of mice treated with UVB or methoxsalen plus UVA radiation.
    Kripke ML; Morison WL; Parrish JA
    J Invest Dermatol; 1981 Jun; 76(6):445-8. PubMed ID: 6453906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
    Koulu L; Jansén CT
    Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and transplantation of murine skin cancers induced by methoxsalen plus ultraviolet (320-400 nm) radiation.
    Kripke ML; Morison WL; Parrish JA
    J Natl Cancer Inst; 1982 Apr; 68(4):685-90. PubMed ID: 7040768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoinactivation and recovery in skin fibroblasts after formation of mono- and bifunctional adducts by furocoumarins-plus-UVA.
    Pohl J; Christophers E
    J Invest Dermatol; 1980 Oct; 75(4):306-10. PubMed ID: 7430696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photocarcinogenesis in the Tg.AC mouse: lomefloxacin and 8-methoxypsoralen.
    Chignell CF; Haseman JK; Sik RH; Tennant RW; Trempus CS
    Photochem Photobiol; 2003 Jan; 77(1):77-80. PubMed ID: 12856886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis.
    Hannuksela M; Karvonen J
    Br J Dermatol; 1978 Dec; 99(6):703-7. PubMed ID: 737133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic transformation of C3H mouse embryo 10T1/2 cells by 8-methoxypsoralen plus UVA radiation.
    Ananthaswamy HN
    J Invest Dermatol; 1985 Aug; 85(2):102-6. PubMed ID: 4020157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.